The Effect of Black Cohosh on Ki67 expression and Tumor Volume: A Pilot Study of Ductal Carcinoma in Situ Patients

Background: Black cohosh (BC) (Cimicifuga racemosa) may prevent and treat breast cancer through anti-proliferative, pro-apoptotic, anti-estrogenic, and anti-inflammatory effects. This study sought to evaluate the effect of BC on tumor cellular proliferation, measured by Ki67 expression, in a pre-operative window trial of ductal carcinoma in situ (DCIS) patients. Methods: Patients were treated pre-operatively for 2 to 6 weeks with BC extract. Eligible subjects were those who had DCIS on core biopsy. Ki67 was measured using automated quantitative immunofluorescence (AQUA) pre/post-operatively. Ki67, tumor volume, and hormone changes were assessed with 2-sided Wilcoxon signed-rank tests, α = .05. Results: Thirty-one patients were treated for an average of 24.5 days (median 25; range 15-36). Ki67 decreased non-significantly (n = 26; P = .20; median pre-treatment 1280, post-treatment 859; range pre-treatment 175-7438, post-treatment 162-3370). Tumor volume, estradiol, and FSH did not change significantly. No grade 3 or 4 adverse events were reported. Conclusions: BC use showed no significant impact on cellular proliferation, tumor volume, or invasive disease upgrade rates in DCIS patients. It was well-tolerated, with no observed significant toxicities. Further study is needed to elucidate BC’s role in breast cancer treatment and prevention. ClinicalTrials.gov Identifier: NCT01628536 https://clinicaltrials.gov/ct2/show/NCT01628536

[1]  M. A. Mirza,et al.  Benefits of Black Cohosh (Cimicifuga racemosa) for Women Health: An Up-Close and In-Depth Review , 2022, Pharmaceuticals.

[2]  D. Rachoń,et al.  Review & meta-analysis: isopropanolic black cohosh extract iCR for menopausal symptoms – an update on the evidence , 2020, Climacteric : the journal of the International Menopause Society.

[3]  M. Crone,et al.  The antiestrogenic effects of black cohosh on BRCA1 and steroid receptors in breast cancer cells , 2019, Breast cancer.

[4]  Christina McKee,et al.  The effects of black cohosh on the regulation of estrogen receptor (ERα) and progesterone receptor (PR) in breast cancer cells , 2018, Breast cancer.

[5]  T. Cortadellas,et al.  Estimation of tumor size in breast cancer comparing clinical examination, mammography, ultrasound and MRI-correlation with the pathological analysis of the surgical specimen. , 2017, Gland surgery.

[6]  I. Rietjens,et al.  The potential health effects of dietary phytoestrogens , 2016, British journal of pharmacology.

[7]  Prabhjot S. Mundi,et al.  Proteomic modulation in breast tumors after metformin exposure: results from a “window of opportunity” trial , 2017, Clinical and Translational Oncology.

[8]  K. Brown,et al.  New concepts and challenges in the clinical translation of cancer preventive therapies: the role of pharmacodynamic biomarkers , 2015, Ecancermedicalscience.

[9]  Parijatham S. Sivasubramanian,et al.  Breast Cancer Chemoprevention among High‐risk Women and those with Ductal Carcinoma In Situ , 2015, The breast journal.

[10]  K. Crew Addressing barriers to uptake of breast cancer chemoprevention for patients and providers. , 2015, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

[11]  J. Niland,et al.  Tumor Response Ratio Predicts Overall Survival in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy , 2014, Annals of Surgical Oncology.

[12]  J. McGowan,et al.  Black Cohosh and Breast Cancer , 2014, Integrative cancer therapies.

[13]  D. Rimm,et al.  Quantitative assessment Ki-67 score for prediction of response to neoadjuvant chemotherapy in breast cancer , 2014, Laboratory Investigation.

[14]  S. Ciatto,et al.  Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer. , 2011, Radiology.

[15]  Markus Neuhäuser,et al.  Wilcoxon Signed Rank Test , 2006 .

[16]  J. Philbrick,et al.  Patient decisions about breast cancer chemoprevention: a systematic review and meta-analysis. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  A. Ciampi,et al.  Efficacy of black cohosh-containing preparations on menopausal symptoms: a meta-analysis. , 2010, Alternative therapies in health and medicine.

[18]  D. Rimm,et al.  Automated analysis of tissue microarrays. , 2010, Methods in molecular biology.

[19]  E. Sauter,et al.  Black Cohosh: Insights into its Mechanism(s) of Action , 2008, Integrative medicine insights.

[20]  P. Novotny,et al.  Mayo Clinic and North Central Cancer Treatment Group hot flash studies: a 20-year experience , 2008, Menopause.

[21]  H. Henneicke-von Zepelin,et al.  Black cohosh with or without St. John's wort for symptom-specific climacteric treatment--results of a large-scale, controlled, observational study. , 2007, Maturitas.

[22]  T. Rebbeck,et al.  A retrospective case–control study of the use of hormone‐related supplements and association with breast cancer , 2007, International journal of cancer.

[23]  T. Su,et al.  Gene expression analysis of the mechanisms whereby black cohosh inhibits human breast cancer cell growth. , 2007, Anticancer research.

[24]  H. Meden,et al.  Isopropanolic black cohosh extract and recurrence-free survival after breast cancer. , 2007, International journal of clinical pharmacology and therapeutics.

[25]  P. Novotny,et al.  Phase III double-blind, randomized, placebo-controlled crossover trial of black cohosh in the management of hot flashes: NCCTG Trial N01CC1. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  M. Mayo,et al.  Breast-tissue sampling for risk assessment and prevention. , 2005, Endocrine-related cancer.

[27]  Workshop on the Safety of Black Cohosh in Clinical Studies , 2005 .

[28]  R. Saller,et al.  Cimicifuga racemosa Extract Inhibits Proliferation of Estrogen Receptor-positive and Negative Human Breast Carcinoma Cell Lines by Induction of Apoptosis , 2004, Breast Cancer Research and Treatment.

[29]  S. Huber,et al.  Benign breast lesions: minimally invasive vacuum-assisted biopsy with 11-gauge needles patient acceptance and effect on follow-up imaging findings. , 2003, Radiology.

[30]  M. Dowsett,et al.  Effect of raloxifene on breast cancer cell Ki67 and apoptosis: a double-blind, placebo-controlled, randomized clinical trial in postmenopausal patients. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[31]  D. Mckenna,et al.  Black cohosh: efficacy, safety, and use in clinical and preclinical applications. , 2001, Alternative therapies in health and medicine.

[32]  Johannes Gerdes,et al.  Monoclonal antibodies against recombinant parts of the Ki‐67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave‐processed formalin‐fixed paraffin sections , 1992, The Journal of pathology.